LAST DECK OF PHARM 1 Flashcards
Patient with volume overload, who needs progressively higher doses of loop diuretics, usually has:
Loop Resistance
Tx with Chlorothiazide or Metolazone
Metolazone works at GFR <20ml/min
Retains efficacy at supa low GFRs!
Work on collecting duct:
- Amiolioride (K)
- Triamterne (K)
- Spirnolactone (Ald)
How do you fix Loop Resistance?
- If on oral, use parenteral/IV.
- Increase dose (limited).
- Utilize continuous infusion loop diuretics.
- Use a different loop, or add a thiazide diuretic.
Causes of Loop Resistance
- High sodium intake.
- Reduced number of working nephrons from ATN.
- Heavy proteinuria.
- Renal compensation - water and salt reabsorbed at DCT.
What electrolytes are not as easily removed in Renal Replacement Therapy?
RRT - hemodialysis pulls off excess electrolytes to restore a normal balance.
Phosphorous and Magnesium
-High levels in trauma, rhabdomyolysis, tumor lysis syndrome
Why do you avoid calcium when doing RRT on a trauma patient, rhabdomyolysis patient, or tumor lysis syndrome?
High levels of phosphorous in blood.
Calcium and phosphorous can precipitate in the blood when at high conc. and form crystals causing further injury.
Why do RRT patients develop hypocalcemia?
To keep blood from clotting, they use citrate anticoag., which binds to calcium in blood.
Prevents calcium from activating clotting factors. When put back into patients, prevents their blood from clotting.
Kidney failure
Stages?
Causes?
Risks?
Patho? :)
CKD caused by diabetes, HTN, GN.
Stage 1 >90 Stage 2 60-89 Stage 3 30-59 Stage 4 15-29 Stage 5 <15 = Kidney Failure
Risks include DM, HTN, smoking, obesity, proteinuria.
Pathophys of CKD:
Progressive neuropathy leads to loss of nephron mass, glomerular capillary HTN, and proteinuria.
Renal Osteodystrophy
Renal osteodystrophy is a bone disease that occurs when your kidneys fail to maintain proper levels of calcium and phosphorus in the blood.
It’s common in people with kidney disease and affects most dialysis patients.
- Decreased renal fxc
- Increased phosphate levels, which bind Ca and precipitate.
- Hypocalcemia leads to increase in PTH.
- More Ca and Phos reabsorbed, which MAKES THE PROBLEM WORSE.
- Low Vitamin D levels also increase PTH secretion.
CKD Related Mineral & Bone Disorders (3)
Parathyroid Hyperplasia: Result from renal osteodystrophy. Leads to resistance to calcium and vitamin D therapy.
Osteitis fibrosa cystica: High bone turnover disease. Leads to fibrosis of bone marrow and decreased erythropoiesis.
Osteomalacia: softening of bones
S/S CKD
- Uremic symptoms cause fatigue, weakness, confusion, SOB
- Peripheral neuropathies
- Edema
- Change in urine, foaming of urine
- Abdominal distension from ascites
Hemodialysis
Will have a fistula that connects artery and vein in arm. Allows for blood to be taken out of artery, goes through filtrate system, and is put back into the body through the vein.
4 hrs, 3x a week
Peritoneal Dialysis
Putting dialysate solution into the peritoneal space. Passive diffusion, blood transmits waste into the peritoneal space.
In several hours, take the waste out through a drain. Takes 20-30mins.
Management of CKD Diet
Limit protein to 0.8 g/kg/day
Limit sodium intake to <2g/day
Stop smoking
Start exercising
How do you tx a diabetic with CKD?
ACEI or ARB to prevent progression, titrate the drug until GFR drops or you have a significant elevation in serum K occur.
Metformin for diabetes, continued until GFR <30ml/min or SCr >1.5 in males or 1.4 in females.
Stop the drug or it can accumulate at higher levels and form fatal lactic acidosis. :(
How do you treat a patient with CKD and HTN?
- ACEI or ARB = 1st line in DM
- Thiazide diuretics if not sufficient to control BP.
- Manage BP - 140/90 to decrease albumin excretion, 130/80 if possible.
How do you treat anemia in CKD?
Decreased production of erythropoietin from interstitial fibroblasts, which are damaged. Develop normochromic, normocytic anemia.
Tx: Erythropoiesis stimulating agents (ESA) and iron supplementation.
Need to take both for ESA to be effective.
Monitor: oxyhemoglobin
Target Hemoglobin in Anemia Tx:
Pt w/ hemoglobin b/w 9-10, ESA should be considered.
D/C ESA when Hgb is above 10 (11 in RRT pts).
If you continue treating above 13g/dL of hemoglobin = increased mortality, due to thrombosis.
Dose ESA w/ iron.
What are the Erythropoiesis Stimulating Agents?
Epoetin alfa (Epogen, Procrit) Darbepoetin alfa (Aranesp)
Black box warning:
- Increased risk of death, MI, stroke, VTE (sludging of blood, leads to clotting off).
- Increased risk of cancer.
Dose 3-4x a week.
ADR: HTN and vascular access thrombosis.
What do you monitor in CKD patient receiving ESA?
Monitor iron status.
Also, make sure you have adequate intake of B12 and folate - can be diminished by RRT.
Oral intake of iron alone may be insufficient for CKD patients, because their absorption is decreased to 10% (100% in those who are healthy).
Iron Preparations
Oral. Different doses of elemental iron in each.
- Ferrous sulfate
- Ferrous gluconate
- Ferrous fumarate
IV
- Iron Dextran
- Sodium ferric gluconate
- Iron sucrose (most commonly used)
- Ferumoxytol
ADR of Iron Preps
Constipation, nausea, abdominal cramping, black discoloration of stool
TELL PATIENT THEIR STOOL WILL BE BLACK.
Allergic reactions: Hypotension, headaches, and dizziness. Can be fixed by lowering the infusion rate!
TEST Q!
Can also develop arthralgia and arthritis.
How do you select an iron prep?
- Oral therapy if possible. Has less side effects.
- RRT patients are more likely to need IV prep.
Monitor:
- Iron status every 3 months while on ESA.
- Monthly, when titrating dose.
-Hgb, measure every 3 months, but monthly in RRT. When alterring, monitor weekly.
Treatment goals for CKD Related Mineral & Bone Disorders
- Normalize biochemical parameters.
- Prevent dentrimental consequences.
Limit Ca * P product to <55
Less chance of crystal formation
Nonpharmacologic therapy for CKD Related Mineral & Bone Disorders
Limit dietary phosphate intake <800mg per day.
Avoid cola, nuts, beer.
Dialysis won’t pull phosphate out.
What drugs treat CKD related mineral and bone disorder?
Phosphate binders:
- Calcium carbonate
- Calcium Acetate
- Sevelamer Carbonate
- Lanthanum Carbonate
- Aluminum Hydroxide
Bind to phosphate ingested through GI tract and prevent it from being absorbed.
- Used for hypocalcemia in early CKD.
- Calcium Carbonate: Give prior to meals
Why is Aluminum Hydroxide limited use in B&M disorders in CKD?
Aluminum will accumulate and can cause toxicity.
Sevelamer Carbonate
Phosphate binder
- Nonabsorbable hydrogel
- Lowers LDL, raises HDL
- Nice side effect
ADR phosphate binders
- N/V, diarrhea, constipation
- Hypercalcemia with calcium based products
Drug to drug interactions
- Calcium salts can bind to iron, zinc, and FQ.
- Take one hour before or 3 hours after.
Vitamin D Therapy
Ergocalciferol and cholecalciferol must be converted by the kidney to active form.
Calcitriol is an active form - stimulates absorption of calcium.
Leads to hypercalcemia and hyperphosphatemia.
Paracalcitrol - actives PTH receptors, but does NOT increase calcium and phosphate absorption.
Cinacalcet (Sensipar)
Sensitizes PTH receptors to effects of calcium.
Reduces PTH concentrations.
Will have enough calcium and not have as much PTH.
Manifestations of DIKD
AB abnormalities Electrolyte imbalance Urine sediment Proteinuria Pyuria Hematuria Decreased GFR*
Clinical manifestation, signs, and symptoms of DIKD
- Decline in GFR
- Rise in SCr and BUN
-Anorexia, malaise, vommiting, SOB, edema
- Decreased urine output, with progression to HTN and volume overload.
- Esp with NSAIDs, ACEI, and contrast induced nephropathy (CIN).
Signs of PCT injury
Metabolic acidosis with bicarbonaturia, glycosuria, hypophosphatemia, and hypokalemia.
Signs of DCT injury
Polyuria due to impaired urinary concentration, metabolic acidosis from impaired acidification and hyperkalemia.
What can cause ATN?
Aminoglycosides Radio contrast media Cisplatin Amphotericin B Foscarnet Pentamidine Foscarnet Osmotically active agents, like colloids and mannitol
What drugs can cause osmotic nephrosis?
Mannitol
Dextran
IV immunoglobulin
What drugs can cause hemodynamically mediated kidney injury?
ACEI
ARBS
NSAIDs
Cephalosporins, tacrolimus
What drugs causes obstructive nephropathy?
Acyclovir Sulfonamides Indinavir Foscarnet Methotrexate
What drugs cause nephrolithiasis?
Sulfonamides
Triamterene
Indinavir
What drugs causes glomerular disease?
Lithium
NSAIDs
Pamidronate
What drugs can cause acute allergic interstitial nephritis?
PCNs Cipro NSAIDs PPIs Loops
What drugs can cause vasculitis or thrombosis?
Hydralazine
Allopurinol for gout
Methamphetamines
Cyclosporine
What drugs can cause cholesterol emboli?
warfarin
thrombolytics
Aminoglycosides and ATN
Tobramycin
Gentamycin
ATN occurs in 10% of patients, 58% of those critcally ill. - Happens when there is cumulation of drug in proximal epithelial cells. Generates reactive oxygen species that damage the mitochondria.
Will have progressive increase in BUN and Cr.
Reversible if you discontinue therapy.
Risk factors
- large total dose
- prolonged therapy
- trough >2mcg/mL
- concurrent nephrotoxins with use
How do you prevent aminoglycoside damage to the kidney?
Careful patient selection, alternative antibiotic use if possible.
Limit concurrent nephrotoxic usage.
- Pharmacokinetic monitoring to achieve certain troughs.
- Once daily doses are used now, rather than 3x per day.
If ATN develops, discontinue.
Radiographic contrast media and ATN
Presentation: 24-48hrs after administration of contrast. Oliguria.
Contrast will induce a 50% reduction in blood flow causing renal ischemia and direct cellular toxicity. Occurs with high osmolar agents.
How do you avoid contrast induced ATN?
Isotonic Crystalloids - Used to maintain normal blood volume prior to contrast exposure and continued 6-24 hours after exposure.
AVOID ATN by using smallest dose possible, non-iodonated contrast agent, or low isoosmolar agent.
Other preventative agents to use:
- Sodium bicarbonate, but wasn’t very helpful.
- N-acetylcysteine (Mucomyst) - benefits patients at high risk for contrast induced nephropathy. Also good for tylenol OD.
Cysplatin Nephrotoxicity
Used for solid tumors. Doses are limited by nephrotoxicity.
Impairs tubular reabsorption.
Decreased urinary concentration ability.
Leads to polyuria, decreased GFR, and electrolyte wasting.
Drug accumulates in proximal epithelial tubular cells causing necrosis.
How do you prevent cysplatin induced nephropathy?
Prevent by doing dose reduction and decreased frequency of admin.
Avoid concurrent nephrotoxins.
Vigorous hydration with NS can flush the kidneys.
What is the antidote used to chelate cisplatin in normal cells?
Amifostine (Ethyol)
Give 30mins before cisplatin to avoid kidney injury in high risk patients.
Need supportive care and hemodialysis to replace electrolytes.
Amphotericin B and ATN
Used for severe fungal infections.
Leads to renal tubular acidosis and wasting of K, Na, and Mg. Occurs days to weeks after initiation.
Causes direct tubular cell damage. Interacts with ergosterol in cell membrane to kill fungal cells, but damages our cells as well.
How do you prevent amphotericin B ATN?
Liposomal formations (AmBisome)
Embed the drug within the bilayer of the liposome med instead of your own cells. Expensive therapy.
Also need adequate hydration, longer infusion times, and can do electrolyte repalcement PRN.
Intratubular obstruction
Direct precipitation of drug crystals, which causes obstruction, nephritis, and acute tubular necrosis.
Can cause preciptation of tissue degradation products like tumor lysis syndrome and rhabdomyolysis.
How do you prevent tumor lysis syndrome from intratbular obstruction?
Can cause precipitation of uric acid crystals.
Avoid by staying hydrated and allopurinol (Zyloprim).
How does rhabdomyolysis cause intratubular obstruction?
Can cause precipitation of myoglobin.
Can be caused by by using HMG-CoA reductase inhibitors and CYP3A4 inhibitors.
AKI is a cause of drug precipitation - Why? What drugs?
it causes low urine volumes, low drug solubility, and volume depletion.
Can be caused by acyclovir, foscarnet (precipitations calcium), and methotrexate.
Total Body Water
Intracellular compartment
- Potassium
- Organic and inorganic phosphates
Extracellular compartment
- Sodium
- Chloride
- Bicarbonate
Balance maintained by Na-K-ATPase pump.
Osmolality equal in ICF and ECF.
Isotonic fluids (0.9% NaCl)
No net shift in ICF and ECF
Hypertonic solutions
>0.9% NaCl
Decrease in ICF and increase in ECF.
Water shunts out of the cell, ICF, and into the intravascular space, ECF.
Good for cerebral edema to draw water out of the space pushing on the brain.
Hypotonic solution
<0.9% NaCl
Increase in ICF and decrease in ECF.
D5W
Free water; doesn’t have solutes in it to keep it in intravascular space.
Will have 40% in the extracellular space and 60% in the intracellular fluid.
0.45% NaCl
Hypotonic solution, larger volume stays in extracellular space with some intracellular.
0.9% NaCl
Isotonic; all of it stays in the extracelluar fluid. Same concentration as blood.
3% NaCl
Will draw water out of the intracellular space and shuttle to extracellular fluid.
Serum Sodium
tightly regulated; determines plasma osmolality and blood volume.
Kidney regulates water extration via hypothalamaus.
Also affected by glucose and BUN.
Arginine Vasopressin (AVP)
Also known as ADH.
Released from pituitary when increased response in osmolality. Too high solute content (dehydrated), will release AVP.
Inserts aquaporin channels into tubular lumen for water to be reabsorbed.
Increases thirst.
Stimulates RAAS, which increase BP and amount of water retention.
Hypertonic Hyponatremia
- Excess effective osmoles
- Dilute sodium in blood
- Seen with glucose > 500.
- Glucose switches osmolality to ECF.
Every increase in glucose, drops the serum sodium. Can be caused by other osmotic agents like mannnitol.
Hypovolemic Hypotonic Hyponatremia
Due to excessive fluid loss, from diarrhea, vomiting, and diuretics.
Stimulates release of AVP. High urine osmolality, because AVP concentrates it.
Common with thiazides.
Euvolemic Hypotonic Hyponatremia
Normal amount of ECF Na, increases TBW and ECF volume.
Most often caused by SIADH (syndrome of inapropriate ADH secretion).
- Small cell lung, pancreatic cancer
- Pulmonary disease, TB, PNA, ARDS
- Polydipsia
- Head trauma, stroke
Drug induced causes of SIADH
Nicotine, tricyclic antidepressants, opioids, haloperidol
Increased sensitivity to ADH
acetaminopehn, carbamazepine, Iamotrigine, NSAIDs
MIXED of increased ADH release and sensitivity to ADH
Methylenedioxymethamphetamine
ACEI
SSRI